|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.168
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.145
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.129
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.109
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.107
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.106
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.106
|
|
|
|
organ growth
|
GO:0035265 |
117 |
0.090
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.083
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.083
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.071
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.063
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.063
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.061
|
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.060
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.059
|
|
|
|
paraxial mesodermal cell fate commitment
|
GO:0048343 |
2 |
0.058
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.056
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.055
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.055
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.054
|
|
|
|
metanephric loop of henle development
|
GO:0072236 |
4 |
0.053
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.052
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.052
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.051
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.051
|
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.049
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.048
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.047
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.047
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.047
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.047
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.047
|
|
|
|
ensheathment of neurons
|
GO:0007272 |
76 |
0.046
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.046
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.045
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.045
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.043
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.042
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.042
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.042
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.040
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.040
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.039
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.038
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.037
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.037
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.037
|
|
|
|
somatic stem cell maintenance
|
GO:0035019 |
47 |
0.037
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.037
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.036
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.036
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.036
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.036
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.036
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
126 |
0.035
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.035
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.034
|
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.034
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.034
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.034
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.034
|
|
|
|
carbon catabolite activation of transcription
|
GO:0045991 |
4 |
0.033
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.033
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.033
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.033
|
|
|
|
oviduct development
|
GO:0060066 |
3 |
0.033
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
149 |
0.033
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.032
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.032
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.032
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.032
|
|
|
|
conditioned taste aversion
|
GO:0001661 |
4 |
0.032
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.031
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.031
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.031
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.030
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.030
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.030
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.030
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.030
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.030
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.030
|
|
|
|
carbon catabolite regulation of transcription
|
GO:0045990 |
4 |
0.030
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.030
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.029
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.029
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.029
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.028
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.028
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.028
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.028
|
|
|
|
nephrogenic mesenchyme development
|
GO:0072076 |
3 |
0.027
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.027
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.027
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.027
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
52 |
0.027
|
|
|
|
regulation of cartilage development
|
GO:0061035 |
44 |
0.027
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.027
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.027
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.026
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.026
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.026
|
|
|
|
neural precursor cell proliferation
|
GO:0061351 |
121 |
0.026
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.026
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.026
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.025
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.025
|
|
|
|
negative regulation of apoptotic process involved in outflow tract morphogenesis
|
GO:1902257 |
2 |
0.025
|
|
|
|
trachea cartilage morphogenesis
|
GO:0060535 |
4 |
0.024
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.024
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.024
|
|
|
|
odontogenesis of dentin containing tooth
|
GO:0042475 |
66 |
0.024
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.024
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.024
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.024
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.024
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.024
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.024
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.024
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.024
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.024
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.023
|
|
|
|
cell differentiation in spinal cord
|
GO:0021515 |
53 |
0.023
|
|
|
|
intestinal epithelial structure maintenance
|
GO:0060729 |
4 |
0.023
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.023
|
|
|
|
regulation of ketone biosynthetic process
|
GO:0010566 |
2 |
0.023
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.023
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.023
|
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.023
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.023
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.023
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.022
|
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.022
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.022
|
|
|
|
positive regulation of stem cell proliferation
|
GO:2000648 |
59 |
0.022
|
|
|
|
thyroid stimulating hormone secreting cell differentiation
|
GO:0060129 |
4 |
0.022
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.022
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.022
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.022
|
|
|
|
fibroblast growth factor receptor signaling pathway
|
GO:0008543 |
46 |
0.022
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
38 |
0.022
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.022
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.022
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.022
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.022
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.022
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.021
|
|
|
|
negative regulation of cell morphogenesis involved in differentiation
|
GO:0010771 |
48 |
0.021
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.021
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.021
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.021
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.021
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.020
|
|
|
|
brain segmentation
|
GO:0035284 |
3 |
0.020
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.020
|
|
|
|
activation of transmembrane receptor protein tyrosine kinase activity
|
GO:0007171 |
3 |
0.020
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
25 |
0.020
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.020
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.020
|
|
|
|
ectoderm formation
|
GO:0001705 |
3 |
0.020
|
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.020
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.020
|
|
|
|
renal outer medulla development
|
GO:0072054 |
2 |
0.020
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.020
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.020
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.020
|
|
|
|
spinal cord association neuron differentiation
|
GO:0021527 |
14 |
0.020
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.019
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
45 |
0.019
|
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.019
|
|
|
|
regulation of transcription from rna polymerase iii promoter
|
GO:0006359 |
2 |
0.019
|
|
|
|
axis elongation involved in somitogenesis
|
GO:0090245 |
4 |
0.019
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.019
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.019
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.019
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.019
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.019
|
|
|
|
negative regulation of hormone metabolic process
|
GO:0032351 |
4 |
0.019
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.019
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.019
|
|
|
|
midbrain development
|
GO:0030901 |
35 |
0.019
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.019
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.019
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.019
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.019
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.019
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.019
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.019
|
|
|
|
palate development
|
GO:0060021 |
76 |
0.019
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.019
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.019
|
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.018
|
|
|
|
midbrain hindbrain boundary maturation during brain development
|
GO:0022004 |
1 |
0.018
|
|
|
|
cardiac ventricle development
|
GO:0003231 |
83 |
0.018
|
|
|
|
mesangial cell differentiation
|
GO:0072007 |
4 |
0.018
|
|
|
|
auditory receptor cell fate specification
|
GO:0042667 |
1 |
0.018
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.018
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
41 |
0.018
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.018
|
|
|
|
mesoderm morphogenesis
|
GO:0048332 |
64 |
0.018
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.018
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.018
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.018
|
|
|
|
carbon catabolite repression of transcription from rna polymerase ii promoter
|
GO:0000437 |
1 |
0.018
|
|
|
|
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration
|
GO:0014834 |
3 |
0.018
|
|
|
|
trabecula formation
|
GO:0060343 |
24 |
0.018
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.018
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.018
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.018
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.018
|
|
|
|
planar cell polarity pathway involved in heart morphogenesis
|
GO:0061346 |
3 |
0.018
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.018
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.017
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.017
|
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.017
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.017
|
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.017
|
|
|
|
eye photoreceptor cell development
|
GO:0042462 |
31 |
0.017
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.017
|
|
|
|
epithelial cell morphogenesis
|
GO:0003382 |
41 |
0.017
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.017
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.017
|
|
|
|
determination of left right symmetry
|
GO:0007368 |
80 |
0.017
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.017
|
|
|
|
canonical wnt signaling pathway involved in regulation of cell proliferation
|
GO:0044340 |
3 |
0.017
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.017
|
|
|
|
zygotic determination of anterior posterior axis embryo
|
GO:0007354 |
3 |
0.017
|
|
|
|
regulation of action potential
|
GO:0098900 |
4 |
0.017
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.017
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.017
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.016
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.016
|
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.016
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.016
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.016
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.016
|
|
|
|
endocrine pancreas development
|
GO:0031018 |
29 |
0.016
|
|
|
|
fibroblast growth factor production
|
GO:0090269 |
4 |
0.016
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.016
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.016
|
|
|
|
heart growth
|
GO:0060419 |
45 |
0.016
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.016
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.016
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.016
|
|
|
|
cardiac right atrium morphogenesis
|
GO:0003213 |
3 |
0.016
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.016
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.016
|
|
|
|
lung morphogenesis
|
GO:0060425 |
50 |
0.016
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.016
|
|
|
|
negative regulation of hormone biosynthetic process
|
GO:0032353 |
4 |
0.016
|
|
|
|
planar cell polarity pathway involved in cardiac right atrium morphogenesis
|
GO:0061349 |
2 |
0.016
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.016
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.016
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.016
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.016
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.015
|
|
|
|
rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0051123 |
3 |
0.015
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.015
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.015
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.015
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.015
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.015
|
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.015
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.015
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.015
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.015
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.015
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.015
|
|
|
|
regulation of stem cell differentiation
|
GO:2000736 |
50 |
0.015
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.015
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.015
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
39 |
0.015
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.015
|
|
|
|
paramesonephric duct development
|
GO:0061205 |
3 |
0.015
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.015
|
|
|
|
positive regulation of interleukin 8 production
|
GO:0032757 |
2 |
0.015
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.015
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.015
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.015
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.015
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.015
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.014
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.014
|
|
|
|
asymmetric stem cell division
|
GO:0098722 |
3 |
0.014
|
|
|
|
neural tube patterning
|
GO:0021532 |
43 |
0.014
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.014
|
|
|
|
negative regulation of mesenchymal cell proliferation
|
GO:0072201 |
3 |
0.014
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.014
|
|
|
|
regulation of heart growth
|
GO:0060420 |
31 |
0.014
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.014
|
|
|
|
phenol containing compound biosynthetic process
|
GO:0046189 |
21 |
0.014
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.014
|
|
|
|
development of primary female sexual characteristics
|
GO:0046545 |
73 |
0.014
|
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.014
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.014
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.014
|
|
|
|
cardiac muscle tissue growth
|
GO:0055017 |
37 |
0.014
|
|
|
|
regulation of norepinephrine secretion
|
GO:0014061 |
2 |
0.014
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.014
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.014
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.014
|
|
|
|
regulation of bmp signaling pathway
|
GO:0030510 |
60 |
0.014
|
|
|
|
non canonical wnt signaling pathway involved in heart development
|
GO:0061341 |
3 |
0.014
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.014
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.014
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.014
|
|
|
|
somatotropin secreting cell development
|
GO:0060133 |
2 |
0.014
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.014
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.014
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.014
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.014
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.014
|
|
|
|
spinal cord development
|
GO:0021510 |
81 |
0.014
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.014
|
|
|
|
norepinephrine secretion
|
GO:0048243 |
2 |
0.014
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.014
|
|
|
|
regulation of kidney development
|
GO:0090183 |
40 |
0.014
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.014
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.014
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.014
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.014
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.014
|
|
|
|
generation of ovulation cycle rhythm
|
GO:0060112 |
1 |
0.014
|
|
|
|
cell proliferation in forebrain
|
GO:0021846 |
30 |
0.013
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.013
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.013
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.013
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.013
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.013
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.013
|
|
|
|
cardiac muscle cell proliferation
|
GO:0060038 |
31 |
0.013
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.013
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.013
|
|
|
|
positive regulation of catecholamine secretion
|
GO:0033605 |
2 |
0.013
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.013
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.013
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.013
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.013
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.013
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.013
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.013
|
|
|
|
cell communication by chemical coupling
|
GO:0010643 |
2 |
0.013
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.013
|
|
|
|
embryonic heart tube development
|
GO:0035050 |
65 |
0.013
|
|
|
|
transdifferentiation
|
GO:0060290 |
1 |
0.013
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.013
|
|
|
|
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis
|
GO:0061350 |
2 |
0.013
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.013
|
|
|
|
glomerular mesangial cell differentiation
|
GO:0072008 |
3 |
0.013
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.013
|
|
|
|
developmental induction
|
GO:0031128 |
34 |
0.013
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.013
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.013
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.013
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.013
|
|
|
|
milk ejection
|
GO:0060156 |
1 |
0.013
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.013
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.013
|
|
|
|
dna templated transcriptional preinitiation complex assembly
|
GO:0070897 |
4 |
0.013
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.013
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.013
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.013
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.013
|
|
|
|
positive regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090100 |
43 |
0.012
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.012
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000432 |
3 |
0.012
|
|
|
|
planar cell polarity pathway involved in ventricular septum morphogenesis
|
GO:0061348 |
2 |
0.012
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.012
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.012
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.012
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.012
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.012
|
|
|
|
asymmetric neuroblast division
|
GO:0055059 |
1 |
0.012
|
|
|
|
carbon catabolite activation of transcription from rna polymerase ii promoter
|
GO:0000436 |
4 |
0.012
|
|
|
|
endodermal cell fate specification
|
GO:0001714 |
4 |
0.012
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.012
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.012
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.012
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.012
|
|
|
|
notch signaling pathway
|
GO:0007219 |
71 |
0.012
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.012
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.012
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.012
|
|
|
|
bronchiole development
|
GO:0060435 |
3 |
0.012
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.012
|
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.012
|
|
|
|
pancreatic pp cell fate commitment
|
GO:0003329 |
2 |
0.012
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.012
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.012
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.012
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.012
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.012
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter by glucose
|
GO:0000433 |
1 |
0.012
|
|
|
|
forebrain regionalization
|
GO:0021871 |
25 |
0.012
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.012
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.012
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.012
|
|
|
|
sa node cell action potential
|
GO:0086015 |
4 |
0.012
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.012
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.012
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.012
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.012
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.012
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.012
|
|
|
|
artery development
|
GO:0060840 |
53 |
0.012
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.012
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.012
|
|
|
|
regulation of renin secretion into blood stream
|
GO:1900133 |
4 |
0.012
|
|
|
|
mesenchyme morphogenesis
|
GO:0072132 |
32 |
0.012
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.012
|
|
|
|
establishment of planar polarity involved in neural tube closure
|
GO:0090177 |
15 |
0.012
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.011
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.011
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.011
|
|
|
|
positive regulation of transcription by glucose
|
GO:0046016 |
3 |
0.011
|
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.011
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.011
|
|
|
|
positive regulation of dopamine secretion
|
GO:0033603 |
2 |
0.011
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.011
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.011
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.011
|
|
|
|
granulosa cell differentiation
|
GO:0060014 |
1 |
0.011
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.011
|
|
|
|
neural tube closure
|
GO:0001843 |
90 |
0.011
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.011
|
|
|
|
calcium independent cell cell adhesion via plasma membrane cell adhesion molecules
|
GO:0016338 |
4 |
0.011
|
|
|
|
cellular response to parathyroid hormone stimulus
|
GO:0071374 |
2 |
0.011
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.011
|
|
|
|
positive regulation of mechanoreceptor differentiation
|
GO:0045633 |
1 |
0.011
|
|
|
|
brain morphogenesis
|
GO:0048854 |
32 |
0.011
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
44 |
0.011
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
33 |
0.011
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.011
|
|
|
|
catecholamine metabolic process
|
GO:0006584 |
30 |
0.011
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.011
|
|
|
|
purine ribonucleotide biosynthetic process
|
GO:0009152 |
59 |
0.011
|
|
|
|
positive regulation of interferon gamma production
|
GO:0032729 |
39 |
0.011
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.011
|
|
|
|
visual perception
|
GO:0007601 |
52 |
0.011
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.011
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.011
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.011
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.011
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.011
|
|
|
|
establishment of organ orientation
|
GO:0048561 |
1 |
0.011
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.011
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.011
|
|
|
|
embryonic heart tube morphogenesis
|
GO:0003143 |
51 |
0.011
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.011
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.011
|
|
|
|
post anal tail morphogenesis
|
GO:0036342 |
23 |
0.011
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.011
|
|
|
|
vascular wound healing
|
GO:0061042 |
3 |
0.011
|
|
|
|
adenohypophysis development
|
GO:0021984 |
14 |
0.011
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.011
|
|
|
|
midbrain hindbrain boundary maturation
|
GO:0021732 |
1 |
0.011
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.011
|
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.011
|
|
|
|
av node cell to bundle of his cell communication
|
GO:0086067 |
2 |
0.011
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.011
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.011
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.011
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.011
|
|
|
|
detection of abiotic stimulus
|
GO:0009582 |
60 |
0.011
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.011
|
|
|
|
cell fate commitment involved in formation of primary germ layer
|
GO:0060795 |
26 |
0.011
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.011
|
|
|
|
regulation of interleukin 6 production
|
GO:0032675 |
55 |
0.011
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.011
|
|
|
|
regulation of ventricular cardiac muscle cell membrane depolarization
|
GO:0060373 |
2 |
0.011
|
|
|
|
spleen development
|
GO:0048536 |
39 |
0.011
|
|
